Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 16, 2016CephalalgiaOpen Access

Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?

View Full Paper
Ask AI
Bookmark
Share

Authors

XZXiChun ZhangCapital UniversityASAndrew M. StrassmanBeth Israel Deaconess Medical CenterVNVictor NovackGeneral / Preventive / Lipids

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2016) studied this question.

synapsesocial.com/papers/6a5d65e1a170fefb8e8a3062https://doi.org/10.1177/0333102416636843
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intranasal Civamide for the Acute Treatment of Migraine Headache2000 · 80 citations
  2. 2The sensory innervation of the calvarial periosteum is nociceptive and contributes to headache-like behavior2014 · 93 citations
  3. 3The TRPA1 channel in migraine mechanism and treatment2013 · 144 citations
  4. 4TRPV1 receptor blockade is ineffective in different in vivo models of migraine2010 · 50 citations